Related Experiment Videos
Thalassemic serum inhibits endothelial cell mitosis in vitro
P Butthep1, A Khuhapinant, A Bunyaratvej
1Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
Insights
Thalassemic serum inhibits endothelial cell growth. This study found that serum from thalassemia patients significantly reduced mitotic activity in human umbilical vein endothelial cells compared to normal serum.
Area of Science:
- Cell Biology
- Hematology
- Endothelial Cell Research
Background:
- Endothelial cells form blood vessel linings.
- Thalassemia affects red blood cells and can impact overall health.
- Understanding endothelial cell behavior is crucial for vascular health.
Purpose of the Study:
- To investigate the effect of thalassemic serum on endothelial cell proliferation.
- To determine if factors in thalassemic serum inhibit endothelial cell mitosis.
Main Methods:
- Human umbilical vein endothelial cells were cultured in vitro.
- Cells were supplemented with different serum types: normal, thalassemic, autologous cord, and fetal bovine serum.
- Mitotic activity was quantified using microscopy.
Main Results:
- Thalassemic serum significantly decreased endothelial cell mitotic activity compared to normal, cord, or fetal bovine serum.
- This inhibitory effect was observed with both beta-thalassemia/HbE and alpha-thalassemic sera.
- The reduction in mitosis was evident by day 3 of culture.
Conclusions:
- Thalassemic sera contain factors that inhibit endothelial cell growth and proliferation.
- These factors appear to act by suppressing mitosis in vitro.
- Further research is needed to identify the specific inhibitory factors in thalassemic serum.
Abstract:
Human umbilical vein endothelial cells were cultured in vitro using Iscove's Modified Dulbecco's Medium (IMDM) supplemented with either pooled normal human serum, or pooled thalassemic serum, or autologous umbilical cord serum, or fetal bovine serum. The mitotic activity was determined under the inverted phase contrast microscope and the number of mitotic cells was counted. Our results showed that the mitotic cells decreased in endothelial cell culture with thalassemic serum as compared with normal human serum, autologous umbilical cord serum or fetal bovine serum. The percentage of mitotic cells decreased on day 3 in the presence of beta-thalassemia/HbE serum from both splenectomized and non-splenectomized patients as compared with normal or autologous umbilical cord serum. In the presence of alpha-thalassemic serum, a similar outcome was also observed. From this study we can conclude that the thalassemic sera might contain factors which affect the endothelial cell growth and proliferation by inhibiting mitosis in vitro.